<SEC-DOCUMENT>0000950170-24-051487-index.html : 20240501
<SEC-HEADER>0000950170-24-051487.hdr.sgml : 20240501
<ACCEPTANCE-DATETIME>20240501193220
ACCESSION NUMBER:		0000950170-24-051487
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20240429
FILED AS OF DATE:		20240501
DATE AS OF CHANGE:		20240501

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Gangloff Scott A.
		CENTRAL INDEX KEY:			0001663253
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38944
		FILM NUMBER:		24904679

	MAIL ADDRESS:	
		STREET 1:		C/O ONCOBIOLOGICS, INC.
		STREET 2:		7 CLARKE DRIVE
		CITY:			CRANBURY
		STATE:			NJ
		ZIP:			08512

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Akero Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001744659
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		601 GATEWAY BOULEVARD, SUITE 350
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		650-487-6488

	MAIL ADDRESS:	
		STREET 1:		601 GATEWAY BOULEVARD, SUITE 350
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>ownership.xml
<DESCRIPTION>3
<TEXT>
Document 1 - file: ownership.html

Document 1 - RAW XML: ownership.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.1
<SEQUENCE>2
<FILENAME>akro-ex24_1.htm
<DESCRIPTION>EX-24.1
<TEXT>
Document 2 - file: akro-ex24_1.htm

</DOCUMENT>
</SEC-DOCUMENT>